Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review

[1] Gal D(2019)Hot topics and trends in cardiovascular research Eur Heart J 40 2363-2374

[2] Thijs B(2019)Heart disease and stroke statistics-2019 update: a report from the American Heart Association Circulation 139 e56-e528

[3] Glanzel W(2020)Impact of regulatory guidance on evaluating cardiovascular risk of new glucose-lowering therapies to treat type 2 diabetes mellitus: lessons learned and future directions Circulation 141 843-862

[4] Sipido KR(2017)Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: should unstable angina be included in the primary end point? Diabetes Care 40 1144-1151

[5] Benjamin EJ(2014)Use of administrative medical databases in population-based research J Epidemiol Community Health 68 283-287

[6] Muntner P(2017)When and how can real world data analyses substitute for randomized controlled trials? Clin Pharmacol Ther 102 924-933

[7] Alonso A(2021)STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies BMJ (Clinical research ed) 372 m4856-1013

[8] Bittencourt MS(2021)Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE Initiative Circulation 143 1002-625

[9] Callaway CW(2015)Validity of diagnostic codes for acute stroke in administrative databases: a systematic review PLoS One 10 e0135834-130

[10] Carson AP(2014)Validity of myocardial infarction diagnoses in administrative databases: a systematic review PLoS One 9 e92286-154

[1] Gal D(2019)Hot topics and trends in cardiovascular research Eur Heart J 40 2363-2374

[2] Thijs B(2019)Heart disease and stroke statistics-2019 update: a report from the American Heart Association Circulation 139 e56-e528

[3] Glanzel W(2020)Impact of regulatory guidance on evaluating cardiovascular risk of new glucose-lowering therapies to treat type 2 diabetes mellitus: lessons learned and future directions Circulation 141 843-862

[4] Sipido KR(2017)Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: should unstable angina be included in the primary end point? Diabetes Care 40 1144-1151

[5] Benjamin EJ(2014)Use of administrative medical databases in population-based research J Epidemiol Community Health 68 283-287

[6] Muntner P(2017)When and how can real world data analyses substitute for randomized controlled trials? Clin Pharmacol Ther 102 924-933

[7] Alonso A(2021)STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies BMJ (Clinical research ed) 372 m4856-1013

[8] Bittencourt MS(2021)Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE Initiative Circulation 143 1002-625

[9] Callaway CW(2015)Validity of diagnostic codes for acute stroke in administrative databases: a systematic review PLoS One 10 e0135834-130

[10] Carson AP(2014)Validity of myocardial infarction diagnoses in administrative databases: a systematic review PLoS One 9 e92286-154